Skip to Main Content

Paper Details

Provocation Testing and Therapeutic Response in a Newly Described Channelopathy: RyR2 Calcium Release Deficiency Syndrome.
Circ Genom Precis Med
15
2022
Ala4142Thr, CRDS, Calcium, Calcium Release, Channelopathy, RyR2, RyR2 Calcium Release Deficiency Syndrome, aborted sudden cardiac death, arrhythmia, calcium, cardiac arrests, cardiac ryanodine receptor, cell model, children, familial arrhythmia syndrome, familial sudden death, flecainide, heritable arrhythmia syndrome, human, metoprolol, mouse, ryanodine, sudden cardiac death, sudden cardiac deaths, ventricular arrhythmia
Author NameAffiliation
John TaylorOxford University Hospitals NHS Trust, The Churchill Hospital
Jenny C TaylorOxford Biomedical Research Centre and Wellcome Centre for Human Genetics (J.C.T., University of Oxford
Jenny C TaylorOxford University Hospitals NHS Trust, The Churchill Hospital
Hugh WatkinsUniversity of Oxford
Hugh WatkinsOxford Biomedical Research Centre and Wellcome Centre for Human Genetics (J.C.T., University of Oxford
  • 1 - 5

Datasets

Release 1.2